Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Benztropine mesylate (Benztropine methanesulfonate) is a centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 29.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 30.00 |
Description | Benztropine mesylate (Benztropine methanesulfonate) is a centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine. |
Targets&IC50 | DAT:118 nM |
In vitro | At doses of 5 mg/kg and 25 mg/kg, Benztropine increases the levels of extracellular dopamine in the striatum of rats in a dose-dependent manner. A daily dose of 3 mg of Benztropine effectively improves tremor and motor scores in patients with Parkinson's disease on the Unified Parkinson's Disease Rating Scale without causing adverse effects such as leukopenia. |
In vivo | In HEK-293 cells treated with [3H]CFT and under the condition of 130 mM sodium ions, the D313N DAT exhibited a slight increase in the apparent equilibrium dissociation constant for Benztropine. The double mutant W84L D313N DAT showed a similar apparent equilibrium dissociation constant for Benztropine when compared to the single mutation. Benztropine inhibited MTSET-induced binding of [3H]WIN to the wild-type dopamine transporter with an EC50 of 28 μM in a concentration-dependent manner. Furthermore, Benztropine demonstrated a protection rate of 32 in the X-A342C DAT construct by shielding Cys-342 from reactivity (EC50 for inhibition of [3H]WIN (4 nM) to IC50 binding). |
Synonyms | Benzotropine mesylate, Benzatropine mesylate, Benztropine methanesulfonate |
Molecular Weight | 403.53 |
Formula | C21H25NO·CH4SO3 |
CAS No. | 132-17-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 74 mg/mL (183.4 mM)
DMSO: 47 mg/mL (116.5 mM)
Ethanol: 75 mg/mL (185.9 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Benztropine mesylate 132-17-2 GPCR/G Protein Immunology/Inflammation Neuroscience Dopamine Receptor AChR Histamine Receptor Benzotropine mesylate Benzatropine mesylate Benzotropine Benzotropine Mesylate disease Benzatropine anti-histamine Inhibitor inhibit Benztropine methanesulfonate Benztropine Muscarinic acetylcholine receptor Parkinson's anticholinergic mAChR Benzatropine Mesylate Benztropine Mesylate dopamine transporter inhibitor